➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Boehringer Ingelheim
Harvard Business School
Express Scripts
Dow

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 5,948,758

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,948,758
Title: Methods for treating various disease states by reducing adhesion of leukocytes of target cells
Abstract:The invention relates to therapeutic methods of using a substantially pure protein comprising the .beta.-subunit of a human glycoprotein involved in cellular adhesion, or a biologically active fragment thereof, or analog thereof. These therapeutic methods are useful for treating auto immune diseases and allograft rejection.
Inventor(s): Springer; Timothy (Chestnut Hill, MA), Kishimoto; Takashi K. (Cambridge, MA), Roberts; Thomas M. (Cambridge, MA)
Assignee: Dana Faber Cancer Institute Inc. (Boston, MA)
Application Number:08/811,027
Patent Claims:see list of patent claims

Details for Patent 5,948,758

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Vericel Corporation MACI autologous cultured chondrocytes IMPLANT 125603 001 2017-01-11   Start Trial Dana Faber Cancer Institute Inc. (Boston, MA) 2007-02-26 search
Vericel Corporation MACI autologous cultured chondrocytes IMPLANT 125603 1 2017-01-11   Start Trial Dana Faber Cancer Institute Inc. (Boston, MA) 2007-02-26 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Boehringer Ingelheim
Dow
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.